Latest Articles

Publication Date
All News Scientific
Woman loses 18st 7.5lbs after 'gamechanger' decision and no injections - The Mirror

Woman loses 18st 7.5lbs after 'gamechanger' decision and no injections The Mirror

Published: Nov. 20, 2025, 6:47 a.m.
Read Full Article
Heterotopic Pregnancy After Intracytoplasmic Sperm Injection With Viable Embryos: A Case Report and Literature Review - Cureus

Heterotopic Pregnancy After Intracytoplasmic Sperm Injection With Viable Embryos: A Case Report and Literature Review Cureus

Published: Aug. 20, 2025, 6:06 a.m.
Read Full Article
'If you're not plump, you're not healthy.' Breaking cultural food norms, 1 injection at a time - MSN

'If you're not plump, you're not healthy.' Breaking cultural food norms, 1 injection at a time MSN

Published: July 13, 2025, 3:22 p.m.
Read Full Article
'If you're not plump, you're not healthy.' Breaking cultural food norms, 1 injection at a time - Yahoo

'If you're not plump, you're not healthy.' Breaking cultural food norms, 1 injection at a time Yahoo

Published: July 11, 2025, 10 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Abilify injection side effects: Common, mild, and serious - Medical News Today

Abilify injection side effects: Common, mild, and serious Medical News Today

Published: April 4, 2025, 9:02 p.m.
Read Full Article
Future of cancer treatment in PD-1 subcutaneous injections - Medical News Today

Future of cancer treatment in PD-1 subcutaneous injections Medical News Today

Published: April 4, 2025, 5 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!